MétaCan
Menu
Back to cohort
Record W2988030531 · doi:10.1016/s0167-8140(19)33327-4

40 Canagliflozin, a New Anti-Diabetic Agent Targeting Cellular Metabolism, Suppresses Survival and Enhances the Response of Non-Small Cell Lung Cancer (NSCLC) to Radiotherapy

2019· article· en· W2988030531 on OpenAlexafffund
Olga‐Demetra Biziotis, Evangelia E. Tsakiridis, Lindsay A. Broadfield, Thomas J. Farrell, Gabe Menjolian, Tammy Mathurin, Bassem Mekhaeil, Panagiotis Zacharidis, Paola Muti, Bassam Abdulkarim, Gregory R. Steinberg, Theodoros Tsakiridis

Bibliographic record

VenueRadiotherapy and Oncology · 2019
Typearticle
Languageen
FieldMedicine
TopicDiabetes Treatment and Management
Canadian institutionsMcGill UniversityMcMaster University
FundersUniversité de MontréalMcGill UniversityCanadian Institutes of Health ResearchHamilton Health Sciences
KeywordsCanagliflozinMedicineOncologyRadiation therapyCancer researchInternal medicineLung cancerDiabetes mellitusType 2 diabetesEndocrinology

Abstract

fetched live from OpenAlex

CARO-ASM 2019 prostatic adenocarcinomas: most are multi-focal and harbour multiple sub-clonal populations.Herein, we determined the robustness of three validated DNA-based genomic biomarkers to intratumoural heterogeneity, and their association with the respective clinical phenotype. Materials and Methods:After obtaining Institutional approval, we queried a prospective registry including 1,054 patients with high-risk prostate cancer who underwent RP between 2001-2013.A case-control cohort (n=42) risk-matched by clinicopathologic prognostic indices was derived, comprising 21 patients that developed early biochemical recurrence (eBCR; <18 months after RP), and 21 with long-term control (LTC; >48 months after RP).Then, we dissected multiple distinct tumour foci per patient (average 3 foci), leading to a total of 119 samples for genomic profiling.For each focus, three genomic DNA-based biomarker scores were calculated: percentage of genome with a copy number aberration (PGA), a 100-loci biomarker, and an optimized 31-loci biomarker derived from the previous.For each patient and biomarker, we considered three scenarios: sampling of only the lowest-score region, the highest-score region, or sampling of all foci and use the mean score across them. Results:We observed high intra-patient genomic divergence between the least and most altered tumour sample, in average representing 6.15% of the genome (i.e. gain or loss of approximately an entire chromosome).Nevertheless, all three biomarkers successfully distinguished eBCR from LTC in this case-control cohort, regardless of which focus, or way of summarizing foci was used: PGA, 100-and 31-loci scores separated the two clinical phenotypes with an AUC ranging from 0.75-0.80,0.76-0.85and 0.76-0.80respectively.No statistical difference between AUCs was observed.Similarly, on time-to-event analyses (Cox proportional hazards modeling) all three biomarkers were significantly associated with BCR-free survival independent of how different foci were summarized.Conclusions: Genomic heterogeneity within patients is very large, and translates in differences in DNA-biomarker scores.Nonetheless, despite the theoretical impact on prognostication, all three genomic biomarkers evaluated were spatially robust and accurately predicted eBCR.Our study provocatively suggests that individual samples may be adequate in patients with high-risk disease.The validity and implications of this findings in patients with low-and intermediate-risk disease, and other genomic biomarkers warrants further investigation.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.009

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.010
GPT teacher head0.278
Teacher spread0.268 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2019
Admission routes2
Has abstractno

Explore more

Same venueRadiotherapy and OncologySame topicDiabetes Treatment and ManagementFrench-language works237,207